Back
ESC Premium Access

Panel discussion.

Session: Late Breaking Pharmacological Science
Topic: Epidemiology, Prognosis, Outcome
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

12 more presentations in this session

Panel discussants.

Access
Video
Like
Thumbnail

CLARIFY - First-line anti-ischemic agents use and long-term clinical outcomes in stable coronary artery disease

Speaker: Doctor E. Sorbets (Paris, FR)

Access
Slides
Video
Like
Thumbnail

FOURIER - Efficacy of PCSK9 inhibition with evolocumab in patients with Metabolic Syndrome

Speaker: Professor P. Deedwania (Fresno, US)

Access
Like
Thumbnail

Panel discussion.

Access
Video
Like
Thumbnail

SAIT - Specific Active immunotherapy (SAIT) against PCSK9 is safe and lowers circulating LDL-C in humans

Speaker: Associate Professor M. Bauer (Vienna, AT)

Access
ESC TV
Like
Thumbnail

Access the full session

Late Breaking Pharmacological Science

Speakers: Doctor E. Sorbets, Professor P. Deedwania, Associate Professor M. Bauer
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources